WO1993010742A3 - Chemical compounds, their preparation and use - Google Patents
Chemical compounds, their preparation and use Download PDFInfo
- Publication number
- WO1993010742A3 WO1993010742A3 PCT/DK1992/000348 DK9200348W WO9310742A3 WO 1993010742 A3 WO1993010742 A3 WO 1993010742A3 DK 9200348 W DK9200348 W DK 9200348W WO 9310742 A3 WO9310742 A3 WO 9310742A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- preparation
- compounds
- chemical compounds
- cns
- preparing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5509722A JPH07502268A (en) | 1991-11-27 | 1992-11-25 | Chemical compounds, their preparation and use |
AU30817/92A AU672182B2 (en) | 1991-11-27 | 1992-11-25 | Piperidine derivatives and their use in treating psychosis |
EP92924586A EP0679085A1 (en) | 1991-11-27 | 1992-11-25 | Chemical compounds, their preparation and use |
FI942468A FI942468A (en) | 1991-11-27 | 1994-05-26 | Chemical compounds, their preparation and use |
NO941965A NO300684B1 (en) | 1991-11-27 | 1994-05-26 | Piperidine Compounds, Pharmaceutical Preparations Containing Them, and Use of the Compounds for the Preparation of a Medication for the Treatment of Psychosis |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPCT/DK91/00354 | 1991-11-27 | ||
DK9100354 | 1991-11-27 | ||
DK71092A DK71092D0 (en) | 1992-05-27 | 1992-05-27 | CHEMICAL COMPOUNDS, THEIR PREPARATION AND USE |
DK0710/92 | 1992-05-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1993010742A2 WO1993010742A2 (en) | 1993-06-10 |
WO1993010742A3 true WO1993010742A3 (en) | 1993-07-22 |
Family
ID=26064501
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DK1992/000348 WO1993010742A2 (en) | 1991-11-27 | 1992-11-25 | Chemical compounds, their preparation and use |
Country Status (4)
Country | Link |
---|---|
JP (1) | JPH07502268A (en) |
AU (1) | AU672182B2 (en) |
NZ (1) | NZ245260A (en) |
WO (1) | WO1993010742A2 (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK60593D0 (en) * | 1993-05-26 | 1993-05-26 | Novo Nordisk As | CHEMICAL COMPOUNDS, THEIR PREPARATION AND USE |
US5482950A (en) * | 1993-10-15 | 1996-01-09 | Eli Lilly And Company | Methods for lowering serum cholesterol |
US5476862A (en) * | 1993-12-21 | 1995-12-19 | Eli Lilly And Company | Methods of increasing thrombomodulin expression |
US5461064A (en) * | 1993-12-21 | 1995-10-24 | Eli Lilly And Company | Methods of inhibiting atrophy of the skin and vagina |
US5708009A (en) * | 1993-12-21 | 1998-01-13 | Eli Lilly And Company | Methods of inhibiting myeloperoxidase activity |
US5441966A (en) * | 1993-12-21 | 1995-08-15 | Eli Lilly And Company | Methods of inhibiting Turner's syndrome |
US6562862B1 (en) * | 1994-10-20 | 2003-05-13 | Eli Lilly And Company | Methods of inhibiting physiological conditions associated with an excess of neuropeptide Y |
GB9500580D0 (en) * | 1995-01-12 | 1995-03-01 | Merck Sharp & Dohme | Therapeutic agents |
US5919800A (en) * | 1995-02-28 | 1999-07-06 | Eli Lilly And Company | Benzothiophene compounds, intermediates, compositions, and methods |
US5856339A (en) * | 1995-02-28 | 1999-01-05 | Eli Lilly And Company | Benzothiophene compounds, intermediates, compositions, and methods |
US5510357A (en) * | 1995-02-28 | 1996-04-23 | Eli Lilly And Company | Benzothiophene compounds as anti-estrogenic agents |
US5856340A (en) * | 1995-02-28 | 1999-01-05 | Eli Lilly And Company | Method of treating estrogen dependent cancers |
US5998441A (en) * | 1995-02-28 | 1999-12-07 | Eli Lilly And Company | Benzothiophene compounds, intermediates, compositions, and methods |
US5998401A (en) * | 1995-02-28 | 1999-12-07 | Eli Lilly And Company | Naphthyl compounds, intermediates, compositions, and methods |
US5977093A (en) * | 1995-02-28 | 1999-11-02 | Eli Lilly And Company | Benzothiophene compounds, intermediates, compositions, and methods |
FR2821356A1 (en) * | 2001-02-23 | 2002-08-30 | Cerep | NOVEL ARYLCARBAMATE AND ARYLUREES DERIVATIVES, PREPARATIONS AND USES |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0368388A2 (en) * | 1988-11-07 | 1990-05-16 | Janssen Pharmaceutica N.V. | 3-Piperidinyl-1,2-benzisoxazoles |
EP0377528A1 (en) * | 1989-01-05 | 1990-07-11 | Lipha, Lyonnaise Industrielle Pharmaceutique | Piperidines, process for their preparation and pharmaceutical compounds containing them |
EP0402644A1 (en) * | 1989-05-19 | 1990-12-19 | Hoechst-Roussel Pharmaceuticals Incorporated | N-(aryloxyalkyl)heteroarylpiperidines and -heteroarylpiperazines,a process for their preparation and their use as medicaments |
EP0428437A1 (en) * | 1989-11-07 | 1991-05-22 | Adir Et Compagnie | 1,2-Benzisoxazole derivatives, process for their preparation and pharmaceutical compositions containing them |
-
1992
- 1992-11-25 WO PCT/DK1992/000348 patent/WO1993010742A2/en not_active Application Discontinuation
- 1992-11-25 JP JP5509722A patent/JPH07502268A/en active Pending
- 1992-11-25 NZ NZ245260A patent/NZ245260A/en unknown
- 1992-11-25 AU AU30817/92A patent/AU672182B2/en not_active Ceased
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0368388A2 (en) * | 1988-11-07 | 1990-05-16 | Janssen Pharmaceutica N.V. | 3-Piperidinyl-1,2-benzisoxazoles |
EP0377528A1 (en) * | 1989-01-05 | 1990-07-11 | Lipha, Lyonnaise Industrielle Pharmaceutique | Piperidines, process for their preparation and pharmaceutical compounds containing them |
EP0402644A1 (en) * | 1989-05-19 | 1990-12-19 | Hoechst-Roussel Pharmaceuticals Incorporated | N-(aryloxyalkyl)heteroarylpiperidines and -heteroarylpiperazines,a process for their preparation and their use as medicaments |
EP0428437A1 (en) * | 1989-11-07 | 1991-05-22 | Adir Et Compagnie | 1,2-Benzisoxazole derivatives, process for their preparation and pharmaceutical compositions containing them |
Non-Patent Citations (1)
Title |
---|
J. Med. Chem., Volume 29, 1986, JOSEPH P. YEVICH et al., "Synthesis and Biological Evaluation of 1-(1,2-Benzisothiazol-3-yl)- and (1,2-Benzisoxazol-3-yl)piperazine Derivatives as Potential Antipsychotic Agents", see page 359. * |
Also Published As
Publication number | Publication date |
---|---|
AU672182B2 (en) | 1996-09-26 |
WO1993010742A2 (en) | 1993-06-10 |
AU3081792A (en) | 1993-06-28 |
NZ245260A (en) | 1995-06-27 |
JPH07502268A (en) | 1995-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1993010742A3 (en) | Chemical compounds, their preparation and use | |
HUT53369A (en) | Process for producing substituted pyrrole and pharmaceutical compositions containing them | |
CA2258548A1 (en) | Phenylamino-substituted tricyclic derivatives for treatment of hyperproliferative diseases | |
CA2141048A1 (en) | Substituted benzylamino nitrogen containing non-aromatic heterocycles | |
PT81007A (en) | Process for the preparation of analgesic 1,2-benzisothiazol-3-ylpiperazine derivatives and of pharmaceutical compositions containing the same | |
IL83363A (en) | Use of indol-3-yl-carboxylic acid endo-8-methyl-8-aza- bicyclo (3,2,1) oct-3-yl ester for the preparation of psycho-active pharmaceutical compositions suitable for the treatment of stress- related psychiatric disorders or for increasing vigilance | |
IE881269L (en) | Steroids | |
IL84944A (en) | Pharmaceutical compositions containing 1,2-dihydro-3h-indazolone derivatives,some new such compounds and their preparation | |
MY120318A (en) | Mixture of primary fatty acids of high molecular weight obtained from sugar cane wax and its pharmaceutical uses. | |
CA2155323A1 (en) | Novel use as anti-inflammatory agents for bis-heterocyclic compounds and pharmaceutical compositions thereof | |
HUT47793A (en) | Herbicide compositions containing 2,6-substituted-pyridine-carboxylic acid derivatives as active components and process for producing the active components | |
MY105538A (en) | Derivatives of thieno-triazolo-diazepine, a preparation process of the same and therapeutic compositions containing them. | |
CA2179733A1 (en) | Anticonvulsant pseudofructopyranose sulfamates | |
ATE48001T1 (en) | CEPHEM COMPOUNDS, PROCESSES FOR THEIR PRODUCTION AND THEIR PHARMACEUTICAL PREPARATIONS. | |
NZ220950A (en) | 1,4-dihydro-4-oxo-quinoline-3-carboxylic acid derivatives and pharmaceutical compositions containing such compounds | |
HUT45537A (en) | Process for producing delta-22 derivatives of ll-f 28249 compounds and pharmaceutical compositions containing them as active components, and insecticide compositions | |
CA2135709A1 (en) | Melatonin derivatives for use in treating sleep disorders | |
HU895241D0 (en) | Process for the preparation of substituted 1,3,5-triazin-trione derivatives and pharmaceutical compositions containing said compounds as active ingredient | |
IE801163L (en) | Paromomycin derivatives | |
HUT47096A (en) | Process for producing 1,2-dithiol-3-thion derivatives and pharmaceutical compositions containing them as active components | |
MY103216A (en) | Nedocromil calcium and use thereof in treatment of reversible obstuctive airways disease | |
HUT45972A (en) | Process for production of derivatives of subsituated amin-methil-5,6,7,8-tetrahydronaphtil-oxi-acetic acid, of medical compositions containing such substances and also of the intermediers | |
UA41871C2 (en) | Derivatives of erythromycin, a process for the preparation thereof and a pharmaceutical composition based thereon | |
DK492989D0 (en) | AMINOPYRROLIDINON, PHARMACEUTICAL PREPARATION CONTAINING SUCH A CONNECTION AND PROCEDURE FOR PRODUCING THEREOF | |
EP0462948A3 (en) | Pharmaceutical compositions comprising 3-amino-epsilon-caprolactames for enhancing learning and memory |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU BG CA CS FI HU JP KR NO PL PT RO RU |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AU BG CA CS FI HU JP KR NO PL PT RO RU |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
CFP | Corrected version of a pamphlet front page |
Free format text: REVISED ABSTRACT RECEIVED BY THE INTERNATIONAL BUREAU AFTER COMPLETION OF THE TECHNICAL PREPARATIONS FOR INTERNATIONAL PUBLICATION |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1992924586 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2117304 Country of ref document: CA Ref document number: 942468 Country of ref document: FI |
|
WWP | Wipo information: published in national office |
Ref document number: 1992924586 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1992924586 Country of ref document: EP |